谷歌浏览器插件
订阅小程序
在清言上使用

Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Post-Switch to Dolutegravir and Rilpivirine in SWORD-1/-2

Journal of Acquired Immune Deficiency Syndromes(2022)

引用 4|浏览5
关键词
atherogenesis biomarkers,inflammation,dolutegravir
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要